MEDS Act

Hozzl · 2022-12-30T03:49:02Z

Explore the details of House Bill 6463 MEDS Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/30/2022, 3:49 AM

Summary of Bill HR 6463

The MEDS Act, also known as Bill 117 hr 6463, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the issue of high prescription drug prices in the United States.

One of the key provisions of the MEDS Act is the establishment of a Prescription Drug Affordability Board, which would be responsible for setting limits on the prices of certain prescription medications. This board would have the authority to review and approve or reject proposed price increases for prescription drugs, with the goal of ensuring that these medications remain affordable for all Americans.

Additionally, the MEDS Act includes measures to increase transparency in the pharmaceutical industry. Drug manufacturers would be required to disclose information about the costs of producing their medications, as well as the prices they charge for these drugs in other countries. This information would help to shed light on the factors driving high drug prices in the US. The MEDS Act also aims to promote competition in the pharmaceutical market by allowing for the importation of cheaper prescription drugs from other countries. This would give Americans access to more affordable medications and help to drive down prices in the US. Overall, the MEDS Act is a comprehensive piece of legislation that seeks to address the issue of high prescription drug prices in the United States through a combination of price controls, transparency measures, and increased competition. If passed, this bill could have a significant impact on the affordability of medications for millions of Americans.

Congressional Summary of HR 6463

Medical Equality and Discrimination Stoppage Act or the MEDS Act

This bill prohibits the Department of Health and Human Services (HHS) from discriminating against or providing preferential treatment to any person or group on the basis of race, color, ethnicity, or national origin. The prohibitions also apply to the administration of HHS programs, including HHS-funded programs administered by states, territories, and private entities.

An individual aggrieved by conduct prohibited under the bill may commence a civil action in the appropriate U.S. district court to obtain relief.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 6463

Bill HR 6463 is currently in the status of Bill Introduced since January 20, 2022. Bill HR 6463 was introduced during Congress 117 and was introduced to the House on January 20, 2022. Bill HR 6463's most recent activity was Referred to the Subcommittee for Indigenous Peoples of the United States. as of January 25, 2022

Bipartisan Support of Bill HR 6463

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 6463

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 6463

MEDS Act

Medical Equality and Discrimination Stoppage Act

To provide for equal protection of the law and to prohibit discrimination and preferential treatment on the basis of race, color, or national origin in the administration of programs of the Department of Health and Human Services, and for other purposes.